Leukemia is an aggressive hematologic neoplastic disease. Therapy-resistant leukemic stem cells (LSCs) may contribute to the relapse of the disease. LSCs are thought to be protected in the leukemia microenvironment, mainly consisting of mesenchymal stem/stromal cells (MSC), endothelial cells, and osteoblasts. Canonical and noncanonical Wnt pathways play a critical role in the maintenance of normal hematopoietic stem cells (HSC) and LSCs. In this review, we summarize recent findings on the role of Wnt signaling in leukemia and its microenvironment and provide information on the currently available strategies for targeting Wnt signaling.
CITATION STYLE
Ruan, Y., Kim, H. N., Ogana, H., & Kim, Y. M. (2020, September 1). Wnt signaling in leukemia and its bone marrow microenvironment. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms21176247
Mendeley helps you to discover research relevant for your work.